Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Immunization | 2 | 2019 | 2019 | 0.46 | Why? |
| Health Knowledge, Attitudes, Practice | 3 | 2019 | 8811 | 0.33 | Why? |
| Parents | 1 | 2017 | 2758 | 0.26 | Why? |
| Gold | 2 | 2018 | 592 | 0.25 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.24 | Why? |
| Influenza, Human | 5 | 2021 | 10779 | 0.23 | Why? |
| Saudi Arabia | 4 | 2021 | 4423 | 0.22 | Why? |
| Attitude of Health Personnel | 1 | 2019 | 4741 | 0.21 | Why? |
| Psychoses, Substance-Induced | 1 | 2021 | 91 | 0.21 | Why? |
| Metal Nanoparticles | 2 | 2018 | 771 | 0.21 | Why? |
| Polypharmacy | 1 | 2021 | 347 | 0.19 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.18 | Why? |
| Chemotherapy, Adjuvant | 1 | 2021 | 606 | 0.18 | Why? |
| Cefotaxime | 1 | 2017 | 31 | 0.18 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2019 | 694 | 0.14 | Why? |
| Central Nervous System | 1 | 2018 | 701 | 0.12 | Why? |
| Suicidal Ideation | 1 | 2021 | 1226 | 0.12 | Why? |
| Klebsiella pneumoniae | 1 | 2017 | 658 | 0.11 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Health Care Costs | 1 | 2017 | 1007 | 0.10 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 1261 | 0.10 | Why? |
| Health Personnel | 1 | 2019 | 29646 | 0.09 | Why? |
| Pharmacists | 1 | 2019 | 1246 | 0.09 | Why? |
| Spain | 6 | 2021 | 15545 | 0.09 | Why? |
| Republic of Korea | 4 | 2021 | 5858 | 0.09 | Why? |
| Suicide | 1 | 2021 | 1500 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.08 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.08 | Why? |
| Perception | 1 | 2017 | 2827 | 0.08 | Why? |
| Cohort Studies | 7 | 2021 | 36005 | 0.07 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.07 | Why? |
| Hospitalization | 5 | 2021 | 54280 | 0.07 | Why? |
| Cross-Sectional Studies | 4 | 2021 | 53120 | 0.07 | Why? |
| Surveys and Questionnaires | 3 | 2019 | 43792 | 0.06 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.06 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.06 | Why? |
| United States | 7 | 2021 | 46150 | 0.06 | Why? |
| Adult | 10 | 2021 | 244371 | 0.06 | Why? |
| Infant | 3 | 2021 | 30274 | 0.06 | Why? |
| Administrative Claims, Healthcare | 1 | 2021 | 124 | 0.06 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Male | 11 | 2021 | 367725 | 0.05 | Why? |
| Fluoroquinolones | 1 | 2021 | 235 | 0.05 | Why? |
| Female | 11 | 2021 | 380317 | 0.05 | Why? |
| Hospitals | 1 | 2019 | 11793 | 0.05 | Why? |
| Ceftriaxone | 1 | 2021 | 365 | 0.05 | Why? |
| Vaccines | 1 | 2017 | 3692 | 0.05 | Why? |
| Depression | 1 | 2021 | 14116 | 0.04 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.04 | Why? |
| Databases, Factual | 2 | 2021 | 6248 | 0.04 | Why? |
| Germany | 2 | 2021 | 9196 | 0.04 | Why? |
| Pharmacovigilance | 1 | 2019 | 501 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.03 | Why? |
| Blood-Brain Barrier | 1 | 2018 | 531 | 0.03 | Why? |
| Enoxaparin | 1 | 2021 | 1064 | 0.03 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.03 | Why? |
| Vaccination | 1 | 2019 | 19050 | 0.03 | Why? |
| Safety | 1 | 2021 | 1583 | 0.03 | Why? |
| Community Pharmacy Services | 1 | 2019 | 426 | 0.03 | Why? |
| Humans | 12 | 2021 | 930598 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Pharmacy Service, Hospital | 1 | 2019 | 645 | 0.03 | Why? |
| United Kingdom | 2 | 2021 | 18046 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Aged | 6 | 2021 | 215776 | 0.03 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Professional Role | 1 | 2019 | 1280 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.02 | Why? |
| Arthritis, Rheumatoid | 1 | 2021 | 2043 | 0.02 | Why? |
| Child | 3 | 2021 | 70012 | 0.02 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.02 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.02 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.02 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Alshammari's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(157)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_